
结论很明确:这个市场不值得进入,已经接近价格战环境。 新品牌只有1个,说明不是典型“30~100+新品牌涌入”的超饱和,但新品可盈利率只有21.43%,过去一年新产品成功率也只有23.08%,而且2026年的新上架里失败明显多于成功,入场难度正在上升,不适合现在下注。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
这个市场不值得进入。 你虽然有50万人民币预算,表面上能覆盖单个ASIN的前期起步,但市场已经是明显的高风险价格战环境:整体可盈利产品只有53.57%,而新品可盈利率只有21.43%,新品牌新品里甚至只有50%样本成功,失败率非常高。更关键的是,低难度并不代表好做,真正的问题是新入场品牌和新产品都在被老品牌压制,靠普通打法很难赢。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场可以直接判定为不值得进入:虽然当前样本里新品牌只有1个,但新上架产品14个里只有3个达到可盈利,成功率只有21.43%;更关键的是,新品牌TTLXBL只有1个成功、1个失败,说明新品牌试错成本高且结果不稳定。 不过这不是“全部失败”的市场,真正能复制的是少数高效产品,而不是盲目堆新品。
对大品牌来说,这里只能学“老品牌打法”,但不能把它理解成低门槛机会。 代表性成功样本是 Vital Pet Life 的 B086813XDT,售价49.95美元,毛利率24.18%,月销8000、月收入3996万美元级别;另一个 B0785Q5C55,售价34.95美元,毛利率29.61%,28,317条评价,月销5000、月收入1747.5万美元级别。它们不是靠低价取胜,而是靠成熟配方、长期口碑和稳定复购。要复制的不是“品牌名”,而是液体鱼油/皮毛护理这类明确需求、价格带清晰、包装规格成熟的思路;但对新进者来说,这类老牌已经把流量和信任吃得很深,预算500,000 CNY只能覆盖单个ASIN的前期投放与履约,远不足以对抗这种规模化优势。
对小品牌来说,唯一能参考的是 TTLXBL 的 B0FNJW4852,而不是老品牌。 这个ASIN是新品牌新上架,售价19.49美元,利润率19.6%,月销2000、月收入3898美元,首月/早期投入约3537.95美元,其中广告约867.15美元,评论只有28条,属于真实可复制的“小品牌成功样本”;它复制的是更轻的包装、更低价格带和更直接的功效表达。但同品牌另一个新上架ASIN B0H69P2F6K 已经是非盈利、无有效销量,说明这个市场不是“上新就能赢”,而是只有少数切口能活下来。结论很明确:市场并不适合新进入者,尤其不适合靠低预算硬冲;如果必须做,小品牌只能围绕低评论、已验证的轻量化产品路径,且要准备明显高于单ASIN前期投入的长期品牌和投放成本。
这个市场不适合进入:新品盈利表现太弱,结构上已经被老牌和大牌主导,属于高风险价格战环境。 新品牌里真正跑出来的只有 TTLXBL,且它只有 1 个可确认盈利新品、1 个亏损新品,成功率仅 50%;更关键的是,这个“成功案例”并不代表普通小品牌可复制,因为它的新款 B0FNJW4852 依靠差异化软咀嚼形态拿到 19.55% 利润率,但另一款 B0H69P2F6K 直接没有销售,说明新入场容错很低。\n\n证据很明确:新品利润分布里,能看到的新品只有 3 个落在 10%~40% 区间,其余 71.43% 都是暂时无法判断或未跑通;没有任何新品达到 40% 以上高利润。 全市场已知利润带里,20%~40% 的产品占主力,但新产品端只有 1 个在 10%~20%、2 个在 20%~30%、1 个在 30%~40%,而 0%~10% 和负利润几乎没有被识别出来,说明不是“好做”,而是“只有少数靠品牌和差异化撑起来”。老牌表现更强:Vital Pet Life 的 B086813XDT、B0785Q5C55、B07194V8ZH 都是 24.18%~29.61% 利润率,且分别有 8612、29317、29317 条评论,明显属于大牌壁垒,不是小商家可对标的路径。Native Pet 也是同样逻辑,B0FR9DK7SG 月销 2000、利润率 34.46%,但品牌整体 4 个产品里 3 个盈利,属于已有品牌势能,而不是“低成本白手起家”。\n\n结论:大品牌可进入,小品牌不建议进入;如果硬要做,小品牌必须走强差异化而不是常规铺货。 你这边预算 50 万人民币,足以覆盖单个 SKU 的前期启动,但这个市场的胜出案例要么来自大牌复用品牌力,要么像 TTLXBL 的 B0FNJW4852 这样靠产品形态差异切入;而要复制这类打法,通常还要额外投入品牌、内容和教育成本,不是单靠 50 万就稳妥。可跟的对象只建议看 Native Pet 的 B0FR9DK7SG、TTLXBL 的 B0FNJW4852,以及 Vital Pet Life 的 B086813XDT / B0785Q5C55 / B07194V8ZH;但从市场状态看,现在不是值得下注的市场。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0CVNQCWMM | Zesty Paws | 2024-02-14 | Yes | $36.47 | 10000pcs | $364700.0 | 31.09% | $113385.23 |
![]() | B086813XDT | Vital Pet Life | 2021-08-01 | Yes | $49.95 | 8000pcs | $399600.0 | 24.18% | $96623.28 |
![]() | B00W1QV7XK | Natural Dog Company | 2015-04-13 | Yes | $28.74 | 9000pcs | $258660.0 | 30.61% | $79175.83 |
![]() | B001L1BM2W | Nutramax Laboratories | 2011-03-24 | Yes | $24.99 | 9000pcs | $224910.0 | 33.61% | $75592.26 |
![]() | B08RK1P78T | Native Pet | 2020-12-22 | Yes | $26.17 | 8000pcs | $209360.0 | 34.15% | $71496.45 |
![]() | B0D3FG3PVL | Chew + Heal Labs | 2024-05-06 | Yes | $29.07 | 9000pcs | $261630.0 | 22.88% | $59860.95 |
![]() | B00W1QVNY8 | Natural Dog Company | 2015-04-13 | Yes | $38.0 | 5000pcs | $190000.0 | 29.58% | $56202.0 |
![]() | B0785Q5C55 | Vital Pet Life | 2018-03-09 | Yes | $34.95 | 5000pcs | $174750.0 | 29.61% | $51743.48 |
![]() | B0CXKHT5K2 | Zesty Paws | 2024-04-24 | Yes | $29.8 | 5000pcs | $149000.0 | 32.78% | $48842.2 |
![]() | B001FB6ECQ | Nutramax Laboratories | 2011-03-24 | Yes | $29.48 | 5000pcs | $147400.0 | 32.29% | $47595.46 |
![]() | B08QSK1CYF | BARK&SPARK | 2020-12-16 | Yes | $22.98 | 9000pcs | $206820.0 | 21.88% | $45252.22 |
![]() | B0FR9DK7SG | Native Pet | 2025-09-16 | Yes | $46.08 | 2000pcs | $92160.0 | 34.46% | $31758.34 |
![]() | B0D45NRR45 | BARK&SPARK | 2024-05-17 | Yes | $22.89 | 5000pcs | $114450.0 | 24.92% | $28520.94 |
![]() | B07194V8ZH | Vital Pet Life | 2017-06-19 | Yes | $24.95 | 3500pcs | $87325.0 | 28.33% | $24739.18 |
![]() | B082BCP45S | Pet Honesty | 2020-02-19 | Yes | $37.89 | 2000pcs | $75780.0 | 30.21% | $22893.14 |
![]() | B084VT1CJ6 | Chew + Heal Labs | 2020-03-02 | Yes | $26.35 | 3000pcs | $79050.0 | 26.9% | $21264.45 |
![]() | B09DB3LV91 | planopaws | 2021-09-21 | Yes | $15.7 | 4000pcs | $62800.0 | 21.1% | $13250.8 |
![]() | B0DK3QVQ8T | BARK&SPARK | 2024-09-25 | Yes | $24.66 | 1950pcs | $48087.0 | 23.23% | $11170.62 |
![]() | B0DWCBR69P | Natural Dog Company | 2025-02-06 | Yes | $49.95 | 700pcs | $34965.0 | 27.75% | $9702.79 |
![]() | B003BARURW | Nutri-Vet | 2013-05-15 | Yes | $18.74 | 2000pcs | $37480.0 | 24.85% | $9313.78 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0FR9DK7SG | Native Pet | 2025-09-16 | Yes | $46.08 | 2000pcs | $92160.0 | 34.46% | $31758.34 |
![]() | B0FCTL5WYW | Pet Honesty | 2025-08-19 | Yes | $28.64 | 900pcs | $25776.0 | 29.94% | $7717.34 |
![]() | B0FNJW4852 | TTLXBL | 2025-08-23 | Yes | $19.49 | 2000pcs | $38980.0 | 19.55% | $7620.59 |
这个市场不值得进入,已经是高竞争、接近价格战的市场。 新品整体盈利率只有21.43%,但在所有可识别样本里,真正成功的新品也只有23.08%,失败新品占76.92%;而老品牌新品的盈利率更低,只有18.18%,说明老牌都在硬扛,新人更难打进去。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
What is the ratio of different brands owning all nonprofitable new products
这个市场不值得进入,已经进入明显的价格战和过度拥挤阶段。 过去一年新品牌里只有3个可确认成功、10个明确失败,成功率只有23.08%,而最新一批2026年新上架里失败数已经明显压过成功,入场只会越来越难。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 3 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/8 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |